Cholamandalam investment and Finance Company has successfully completed the allotment of 76,31,691 equity shares through the conversion of 1,06,300 Compulsorily Convertible Debentures (CCDs). The QIP Committee of the Board of Directors approved this conversion following applications received from six CCD holders during the designated conversion window from January 1 to January 7, 2026.

CCD Conversion Details

The conversion involved 1,06,300 CCDs with a face value of ₹1,00,000 each, totaling ₹1,063 crores in value. These CCDs were originally allotted to eligible qualified institutional buyers on October 5, 2023, carrying a 7.5% coupon rate. The conversion price was set at ₹1,392.88 per equity share, calculated at a 16.50% discount to the seven trading days volume weighted average price of the company's equity shares traded on NSE preceding January 1, 2026.

Impact on Share Capital

The conversion has resulted in a significant increase in the company's share capital structure. The issued capital expanded from 84,47,00,931 shares to 85,23,32,622 shares, while the paid-up capital grew from 84,40,17,161 shares to 85,16,48,852 shares.

Regulatory Compliance and Listing

The company has fulfilled its obligations under Regulation 30 of the SEBI LODR Regulations by informing both NSE and BSE about this conversion. The newly allotted equity shares carry a face value of ₹2.00 each and rank pari-passu with existing equity shares in all respects, including dividends and voting rights. These shares will be listed on both BSE Limited and National Stock Exchange of India Limited.

Original CCD Issuance Background

The CCDs were initially issued in October 2023 as part of a qualified institutional placement, with 2,00,000 CCDs allotted at an issue price of ₹1,00,000 each. The placement document included an early conversion option available on or after September 30, 2025, which enabled the recent conversion activity during the January 2026 window.

This conversion represents a strategic capital restructuring move, providing the CCD holders with equity participation while strengthening the company's equity base. The successful completion of this conversion demonstrates investor confidence in the company's growth prospects and financial stability.

Cholamandalam Investment and Finance Company Limited has announced a board meeting scheduled for January 30, 2026, to review and approve its quarterly financial performance. The meeting will focus on considering the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025.

Board Meeting Details

The company has formally notified both the National Stock Exchange of India Limited and BSE Limited about the upcoming board meeting under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting is scheduled to take place on Friday, January 30, 2026.

Trading Window Closure

In accordance with regulatory requirements and in connection with the impending publication of financial results, Cholamandalam Investment and Finance Company Limited has implemented a trading window closure for designated persons. This restriction will be effective from January 1, 2026, through February 1, 2026, with both dates being inclusive.

Regulatory Compliance

The company has fulfilled its disclosure obligations by informing the stock exchanges about the board meeting schedule. The notification was signed by P. Sujatha, Company Secretary, on January 2, 2026, ensuring timely communication to market participants and regulatory authorities.

The scheduled board meeting represents a routine quarterly review process where the company's directors will evaluate the financial performance for the third quarter of fiscal year 2026. Market participants and investors will await the outcome of this meeting for insights into the company's operational and financial performance during the specified period.